These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25782098)

  • 1. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.
    Hellings JA; Reed G; Cain SE; Zhou X; Barth FX; Aman MG; Palaguachi GI; Mikhnev D; Teng R; Andridge R; Logan M; Butler MG; Han JC
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):150-9. PubMed ID: 25782098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Hellings JA; Arnold LE; Han JC
    Expert Opin Pharmacother; 2017 Apr; 18(6):581-588. PubMed ID: 28335658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.
    Jain S; Andridge R; Hellings JA
    J Autism Dev Disord; 2016 Apr; 46(4):1344-53. PubMed ID: 26687568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders.
    Hellings JA; Jadhav M; Jain S; Jadhav S; Genovese A
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):618-24. PubMed ID: 26485086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paliperidone for irritability in adolescents and young adults with autistic disorder.
    Stigler KA; Mullett JE; Erickson CA; Posey DJ; McDougle CJ
    Psychopharmacology (Berl); 2012 Sep; 223(2):237-45. PubMed ID: 22549762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.
    Wake R; Miyaoka T; Inagaki T; Furuya M; Ieda M; Liaury K; Kishi K; Horiguchi J
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):329-36. PubMed ID: 23782127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder.
    Wink LK; Pedapati EV; Horn PS; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):91-94. PubMed ID: 26465194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
    J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
    Ichikawa H; Hiratani M; Yasuhara A; Tsujii N; Oshimo T; Ono H; Tadori Y
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):84-94. PubMed ID: 28941259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
    Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
    Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.